LON: REDX 65.00GBX

Appointment of Peter Collum, as Chief Financial Officer Redx Pharma begin phase I trial to discover potential of its cancer drug as a combination therapy (proactiveinvestors.co.uk)Dosing of first patients with RXC004 and Anti-PD1

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & events
- News & events
Contact us
- Contact us
- Careers

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & Events
- News & events
Contact
- Contact us
- Careers

Top suggestions

Appointment of Peter Collum, as Chief Financial Officer
Redx Pharma begin phase I trial to discover potential of its cancer drug as a combination therapy (proactiveinvestors.co.uk)
Dosing of first patients with RXC004 and Anti-PD1

Email alerts

Investor centre

Presentations, analyst reports, documents & videos

Reports & Accounts

Contact us

RSS

Copyright © 2021 Redx Pharma Plc

Privacy policy
Cookie policy

Website design & build by Carr Kamasa Design

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy.